Metastasis: Clinical and Experimental Aspects: Developments in Oncology, cartea 4
Editat de Kurt Hellmann, P. Hilgard, Suzanne A. Ecclesen Limba Engleză Paperback – 13 ian 2013
Din seria Developments in Oncology
- 5% Preț: 360.70 lei
- 5% Preț: 384.80 lei
- 5% Preț: 345.71 lei
- 5% Preț: 1096.98 lei
- 5% Preț: 360.86 lei
- 5% Preț: 1125.88 lei
- 5% Preț: 3183.63 lei
- 5% Preț: 371.30 lei
- 5% Preț: 374.57 lei
- 5% Preț: 1417.91 lei
- 5% Preț: 375.34 lei
- 5% Preț: 368.57 lei
- 5% Preț: 1102.10 lei
- 5% Preț: 368.37 lei
- 15% Preț: 604.56 lei
- 5% Preț: 1425.76 lei
- 5% Preț: 1119.10 lei
- 5% Preț: 374.57 lei
- 5% Preț: 1416.09 lei
- 5% Preț: 723.21 lei
- 5% Preț: 713.33 lei
- 5% Preț: 1424.16 lei
- 5% Preț: 718.65 lei
- 5% Preț: 367.64 lei
- 5% Preț: 1423.22 lei
- 5% Preț: 1097.71 lei
- 5% Preț: 3836.15 lei
- 5% Preț: 1100.64 lei
- 5% Preț: 1109.08 lei
- 5% Preț: 1419.39 lei
- 5% Preț: 1439.31 lei
- 5% Preț: 1114.71 lei
Preț: 379.33 lei
Preț vechi: 399.29 lei
-5% Nou
Puncte Express: 569
Preț estimativ în valută:
72.59€ • 75.33$ • 60.68£
72.59€ • 75.33$ • 60.68£
Carte tipărită la comandă
Livrare economică 15-29 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789400989276
ISBN-10: 940098927X
Pagini: 492
Ilustrații: XXXIV, 456 p.
Dimensiuni: 155 x 235 x 26 mm
Greutate: 0.68 kg
Ediția:Softcover reprint of the original 1st ed. 1980
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Oncology
Locul publicării:Dordrecht, Netherlands
ISBN-10: 940098927X
Pagini: 492
Ilustrații: XXXIV, 456 p.
Dimensiuni: 155 x 235 x 26 mm
Greutate: 0.68 kg
Ediția:Softcover reprint of the original 1st ed. 1980
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Oncology
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
The Significance of Metastases to the Surgeon.- The Spread of Rectal Cancer into Veins and the Mechanism of Distant Embolism.- Squamous Carcinomas of the Head & Neck: Patterns and Mechanisms of Local Invasion and Metastasis.- The Relationship between Malignant Melanoma Morphology, Metastases and Patient Survival.- Animal Tumour Models: The Intrusion of Artefacts.- Models of Prostate, Breast, Lung and Intestinal Carcinomas which Metastasize in Rats.- A New In-Vitro Model to Study Tumour Cell Invasion.- Invasiveness and the “Metastatic Potential” of Tumour Cells.- A Possibility of Predicting the Metastatic Potential of Tumours by Implantation into Chick Embryo Blastoderms.- An Experimental Study on the Barrier Function of Lymph Nodes to Tumor Cells.- Metastases from DMBA-Induced Carcinomas in Hamster Cheek Pouch.- Quantitation and Cellular Growth of Occult Metastases of a Rat Mammary Carcinoma.- Comparison of Natural and Artificial Lung Metastases from a Murine Tumour of Spontaneous Origin.- Growth Inhibition of Simulated Metastases by a Large Primary Tumor.- Quantitative Studies on Metastasis using Yoshida Rat Ascites Hepatomas, with Special Reference to the Biological Characteristics in Metastasizability and Drug Sensitivity.- Canine Osteosarcoma and Canine Mammary Carcinoma.- Selection of a Human Malignant Melanoma X Hamster Hybrid Cell Line by Metastasis.- Morphological Aspects of the Interaction of Blood Coagulation and Tumour Dissemination.- Cancer Cell Procoagulant Activity, Warfarin and Experimental Metastases.- Molecular Mechanism of Fibrinolysis and its Potential Role in Metastasis.- Fibrinolysis and Anticoagulation in Colo-Rectal Cancer — The Way Ahead.- Studies on Factors Influencing the Lodgement of Circulating Tumour Cells.- Critical Analysis ofExperimental Models for the Antimetastatic Effects of Anticoagulants.- Effect of Fibrinolysis Inhibition on the Growth and Hematogenous Dissemination of Cancer.- Mechanisms Behind the Inhibiting Effect of Tranexamic Acid on Tumour Growth and Spread.- The Inhibitory Effect of Sulfated Polysaccharides, Ancrod or Tranexamic Acid on Pulmonary Metastases in Animals.- Prostacyclin as a Marker for Diagnosing and Staging Carcinoma of the Prostate.- Prostaglandins and Metastasis.- The Application of a Defibrinogenating Snake Venom Enzyme in Experimental Tumor Metastasis.- Effect of Ticlopidine on Blood-Borne Metastasis.- Failure of RA233 to Affect the Growth of Intravenously Injected Murine Lymphoma Cells.- Failure of Flurbiprofen to Affect the Metastasis of Rodent Sarcomas.- In Vivo and In Vitro Selection of Experimental Metastatic Variants of Rodent Melanoma, Mammary Carcinoma and Lymphosarcoma.- The Role of Tumor Cell-Basement Membrane Interactions in the Metastatic Process.- Morphological and Biochemical Differences of Primary and Metastatic Human Melanoma Cells.- Lewis Lung Carcinoma: Selecting Metastatic Variants.- Malignant Properties of Clones Isolated from a Mouse Fibrosarcoma.- Characteristics of Tumor Cell Clones with Varying Malignant Potential.- Invasion of Lung and Liver Tissue by Different Types of Tumour Cells.- Interactions of Tumor Cells with Isolated Hepatocytes. A Model for the Infiltration of Blood-Borne Tumor Cells in the Liver.- Ultrastructural Features of Intravascular and Extravascular Migration of Cancer Cells.- Characteristics of Metastasizing and Non-Metastasizing Tumors and their Interaction with the Host Immune System in the Development of Metastasis.- Metastatic Potential of Tumor Cells from Spontaneous Metastasis.- Cell Surface Changes Associatedwith the Selection of Spontaneous Metastases.- Intrinsic and Extrinsic Factors Governing the Expression of Metastatic Potential.- Metastatic Potential of SK-Br-3 Cells Treated with L-Cysteine or Ascorbic Acid.- Effect of Pre-Treatment with Antisera Against Choriogonadotropin on the Metastatic Potential of a Rat Adenocarcinoma.- Metastases of Mammary Tumours in BR6 Mice.- Fixation of ?-Melanocyte Stimulating Hormone (?-MSH) to Human Metastatic Melanoma Cells In Vitro and In Vivo.- Metastases of Human Tumours in the Nude Mouse: The Behaviour of Colon Carcinoma Xenografts.- Immune Regression of Metastases Following Hyperthermic Treatment of Primary Tumours.- Clonal Tumor Cell Variants Arising by Adaptation.- Reversibility of Immunological and Antitumoral Effects Produced In Vivo by Particulate ?l–3 Glucans.- Modulation of Tumor Growth and Metastasis by an Acute Inflammation.- Enhancement of Pulmonary Metastases Induced in Mice by Cyclophosphamide: Role of the Immune System.- Antimetastatic Effects of Intrapleurally Injected Corynebacterium Parvum.- Does C. Parvum Treatment Affect Tumour Blood Flow and Hence Metastasis?.- Reticuloendothelial System Function in Cancer Patients Treated with C. Parvum.- Inhibition of Pulmonary Metastasis of Lewis Lung Tumor by Nocardia Rubra-Cell Wall Skeleton or Schizophyllan.- Minimal Residual Disease may be Treated by Chessboard Vaccination with Vibrio Cholerae Neuraminidase (VCN) and Tumor Cells.- Application of the Leukocyte Migration Test (LMT) To Patients with Metastases: Evidence in Favour of a Change in Host Response?.- Computed Tomography in the Staging of Malignancy.- Serial Quantitative Skeletal Scintigraphy in Breast Cancer.- Further Studies on the Effect of Prostaglandin Synthesis Inhibitors and Diphosphonates onTumour-Mediated Osteolysis.- Potential Clinical Use of Diphosphonates against Bone Metastases and Hypercalcaemia of Malignancy.- Multiparametric Biochemical Study in the Diagnosis of Bone Metastasis of Breast Cancer.- Acute Changes in Calcitonin Levels in Lung Cancer Patients Treated with C. Parvum: Do these Reflect In Vivo Killing of Tumour Cells?.- Serial Quantitative Bone Scanning of Metastatic Tumour in Rats.- Experimental Study on Characteristics of Microcirculation in Tumor Tissue, with Reference to Cancer Chemotherapy.- Development of Severe Radiation Pheumonitis in Patients with Oat Cell Carcinoma during Combined Modality Therapy.- Effect of Hemithorax Irradiation of Young Mice on Pulmonary Metastatic Deposits from Subsequently Developing Spontaneous Mammary Tumours.- The Chemotherapy of Micrometastases — An Overview of Current Status.- Adjuvant Razoxane in Resectable Colorectal Cancer.- Changing Aspects in the Surgical Approach to Metastatic Disease; Influence of Chemotherapy on Indications For and Results Of Metastasectomies.- Clinical Study on Selective Enhancement of Drug Delivery by Angiotensin II in Cancer Chemotherapy.- Differences and Similarities in Adjuvant Chemo-Therapy in Mouse and Man.- Drug Response of Two Different In Vitro Tumour Lines Derived from Lung Metastases of 3LL.- Therapeutic Implications of Heterogeneous Tumor Cell Populations.- Effect of Bleomycin Scheduling on Lung Metastases of 3LL and a Subline of Different Metastatic Potential.- Metastasis of Lewis Lung Carcinoma (LL) Regrowing After Cytotoxic Treatments.- Adjuvant Chemotherapy Following Surgery for Small-Cell Carcinoma of the Lung.- Cell Surface Sialylation of Metastatic Variant Murine Tumor Cell Lines.- Potential for Selective Inhibition of Metastasis.- Tumour Load DependentEffectiveness of Cyclophosphamide in Lewis Lung Carcinoma.- Prophylactic Antimetastatic Agents: Dimethyltriazenes, N-Diazoacetylglicine Derivatives and other Neutral Proteinase Inhibitors.- Selective Chemotherapy of Metastasis by Drug Carrying Fat Emulsion or Tumor Specific Antibody.- Treatment of Metastases in Long Bones.- Immunotherapy as Adjuvant Treatment for Residual Tumors.